Table 2 miRNA differentially expressed in CRC patients samples and CRC cell lines.
Mean fold-change (log10RQ) CRC patients samples | Mean fold-change (log10RQ) CRC cell lines | Chromosome localization | Correlation with cancer | |
|---|---|---|---|---|
hsa-miR-133b | -1.01 | -3.38 | 6p12.2 | |
hsa-miR-145 | -0.84 | -4.95 | 5q32 | ↓ CRC, lung, breast cancer. |
hsa-miR-129 | -0.67 | -0.88 | 7q32.1 | |
hsa-miR-124a | -0.64 | -1.11 | 8p23.1 | ↓ lung cancer |
hsa-miR-30-3p | -0.53 | -0.63 | 6q13 | |
hsa-miR-328 | -0.52 | -0.65 | 16q22.1 | |
hsa-miR-19a | 0.49 | 0.96 | 13q31.3 | ↑ CRC, lung cancer, B-cell lymphomas, CLL |
hsa-miR-20 | 0.49 | 1.01 | 13q31.3 | ↑ lung cancer, poorly differentiated HCC |
hsa-miR-21 | 0.78 | 0.48 | 17q23.2 | ↑ CRC, glioblastoma, lung, breast cancer, papillary thyroid carcinoma |
hsa-miR-183 | 0.88 | 1.74 | 7q32.2 | |
hsa-miR-96 | 1.04 | 1.99 | 7q32.2 | |
hsa-miR-31 | 1.09 | 2.59 | 9p21.3 | |
hsa-miR-135b | 1.60 | 1.78 | 1q32.1 |